Anzeige
Mehr »
Donnerstag, 19.02.2026 - Börsentäglich über 12.000 News
Die größte Bewertungslücke im globalen Mental-Health-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoStifel Downgrades Allied Gold Corporation (AAUC) to Hold, Sets C$44 Price Target
Mo10 Best NYSE Stocks to Buy for the Long Term
SoAurora Innovation (AUR) Reports Q4 Loss
SoHere's Why JFrog Ltd (FROG) Price Target Was Raised To $78 by Baird
So17 Biotechnology Stocks with More Than 50% Upside
SoJim Cramer Discusses Broadcom (AVGO) Stock
SoNVIDIA (NVDA) Invented Its Category, Says Jim Cramer
SoAdvanced Micro Devices Inc. (AMD) Was Down Way Too Much, Says Jim Cramer
SoApple (AAPL)'s A Free Rider, Says Jim Cramer
SoDisney (DIS)'s Magic, Not MAGA, Says Jim Cramer
SoGeneral Motors Company (GM) CEO Nailed It, Says Jim Cramer
SoStellantis (STLA) Was Devastating, Says Jim Cramer
SoJim Cramer Discusses CVS Health (CVS) In Detail
SoSalesforce (CRM) is a Great Company, Says Jim Cramer
SoVertiv (VRT)'s Orders Were Incredible, Says Jim Cramer
SoResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings
SoGlobus Medical Inc. (GMED) Gains Positive Attention Amid Improving Outlook
SoSTERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence
SoInspire Medical Systems Inc. (INSP) Confronts Near-Term Headwinds Despite Profitability
SoIDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets
SoInsulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update
SoGE HealthCare Technologies Inc. (GEHC) Expands Healthcare Technology Offerings
SoEdwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update
SoDexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook
SoBoston Scientific Corporation (BSX) Maintains Analyst Ratings Amid Target Adjustments